Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
Go back to Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength| (NASDAQ: CMND) | Delayed: 0.80 -0.06 (6.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $ | |||
| Open | $0.85 | 52 Week Low | $ | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $ | |||
| Volume | 194,696 | |||||
